| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/08/1996 | EP0494178B1 Analysis of carbohydrates |
| 05/08/1996 | EP0446305B1 Systems for amplification/detection of target nucleic acids |
| 05/08/1996 | EP0424473B1 Methods for identification of bacteria |
| 05/08/1996 | CN1122162A Diagnostic kit and method for the simultaneous diagnosis of hepatitis B and C |
| 05/08/1996 | CN1122147A Rapid coliform detection system |
| 05/08/1996 | CN1122139A Improved HCV diagnostic agents |
| 05/08/1996 | CN1031771C Quantification of fibrinogen in whole blood samples |
| 05/08/1996 | CA2135253A1 Compound screening based on a window of chemical-messenger-independent activity |
| 05/07/1996 | US5514786 Compositions for inhibiting RNA activity |
| 05/07/1996 | US5514785 Polymer coated bead for covalent immobilization of oligonucleotides; dipsticks |
| 05/07/1996 | US5514577 Oligonucleotide therapies for modulating the effects of herpes viruses |
| 05/07/1996 | US5514569 Reducing inhibition of a nucleoside 5'-monophosphate on phosphodiesterase i by incubating the enzyme in the presence of a nucleoside 5'-monophosphate degrading enzyme |
| 05/07/1996 | US5514568 Mutagenesis of circular or double-stranded dna |
| 05/07/1996 | US5514561 Fluorogenic and chromogenic β-lactamase substrates |
| 05/07/1996 | US5514560 Substrates for βgalactosidase |
| 05/07/1996 | US5514551 Compositions for the detection of Chlamydia trachomatis |
| 05/07/1996 | US5514550 Nucleic acid test article and its use to detect a predetermined nucleic acid |
| 05/07/1996 | US5514548 Method for in vivo selection of ligand-binding proteins |
| 05/07/1996 | US5514547 Molecular genetic identification using probes that recognize polymorphic loci |
| 05/07/1996 | US5514546 Stem-loop oligonucleotides containing parallel and antiparallel binding domains |
| 05/07/1996 | US5514545 Method for characterizing single cells based on RNA amplification for diagnostics and therapeutics |
| 05/07/1996 | US5514544 Dna sequences for genetic engineering |
| 05/07/1996 | US5514543 Screening for genetic disorders |
| 05/07/1996 | US5514540 Detection of papilloma virus, simplification |
| 05/07/1996 | US5514539 Nucleotide and deduced amino acid sequences of the envelope 1 gene of 51 isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines |
| 05/07/1996 | US5514538 Bicarbonate assay and phosphoenolpyruvate carboxylase enzyme from hyphomicrobium |
| 05/07/1996 | US5514501 Process for UV-photopatterning of thiolate monolayers self-assembled on gold, silver and other substrates |
| 05/05/1996 | CA2162075A1 Modified oligonucleotides, their preparation and their use |
| 05/03/1996 | CA2161946A1 Method for probing the function of a protein |
| 05/02/1996 | WO1996012957A1 Bio-recognition-controlled, ion-flow modulating bio-sensor |
| 05/02/1996 | WO1996012824A2 Use of spermidine to relieve inhibition of ligase chain reaction in a clinical test sample |
| 05/02/1996 | WO1996012822A1 Method for indentifying two nucleic acid base code sequences |
| 05/02/1996 | WO1996012821A1 Method for characterising variability in telomere dna by pcr |
| 05/02/1996 | WO1996012820A1 INTERACTIONS BETWEEN Raf PROTO-ONCOGENES AND CDC25 PHOSPHATASES, AND USES RELATED THERETO |
| 05/02/1996 | WO1996012819A1 Method for measuring the bactericidal and bacteriostatic effects of antimicrobial agents |
| 05/02/1996 | WO1996012811A2 Yeast telomerase components and methods using them |
| 05/02/1996 | WO1996012810A1 Hippocampus-associated proteins, dna sequences coding therefor and uses thereof |
| 05/02/1996 | WO1996012809A2 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
| 05/02/1996 | WO1996012807A2 Hepatitis e virus antigens and uses therefor |
| 05/02/1996 | WO1996012805A1 Alk-7 (activin like kinase), a serine threonine kinase receptor |
| 05/02/1996 | WO1996012799A1 Neutralization of foof allergens by thioredoxin |
| 05/02/1996 | WO1996012797A1 Production and use of human and plant methyltransferases |
| 05/02/1996 | WO1996012736A2 COMPOUNDS AND METHODS FOR INHIBITING β-PROTEIN FILAMENT FORMATION AND NEUROTOXICITY |
| 05/02/1996 | WO1996012502A1 Method of culturing m. bovis in low available iron media and production of infectious bovine keratoconjunctivitis vaccine therefrom |
| 05/02/1996 | WO1996012408A1 Reagents with enhanced performance in clinical diagnostic systems |
| 05/02/1996 | WO1996009386A3 Allelic variation of the serotonin 5ht2c receptor |
| 05/02/1996 | WO1996007100A3 Luciferase labelling method |
| 05/02/1996 | DE4438630A1 Amplification of non-characterised DNA fragments |
| 05/02/1996 | DE4438087A1 Sensor for detecting super-oxide anion |
| 05/02/1996 | DE4438083A1 New aminoalkylphenyl substd. acyl-pyrrolidine or piperidine derivs. |
| 05/02/1996 | CA2652992A1 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
| 05/02/1996 | CA2203825A1 Compounds and methods for inhibiting beta-protein filament formation and neurotoxicity |
| 05/02/1996 | CA2203265A1 Production and use of human and plant methyltransferases |
| 05/02/1996 | CA2203105A1 Hippocampus-associated proteins, dna sequences coding therefor and uses thereof |
| 05/02/1996 | CA2202990A1 Use of spermidine to relieve inhibition of ligase chain reaction in a clinical test sample |
| 05/02/1996 | CA2202912A1 Novel tnf receptor death domain ligand proteins and inhibitors of ligand binding |
| 05/02/1996 | CA2202893A1 Reagents with enhanced performance in clinical diagnostic systems |
| 05/02/1996 | CA2201518A1 Method for measuring the bactericidal and bacteriostatic effects of antimicrobial agents |
| 05/02/1996 | CA2161826A1 Method of measuring interferon activity |
| 05/01/1996 | EP0709679A1 Method and layer structure to determine a substance |
| 05/01/1996 | EP0709667A2 Method of calibration for an apparatus for the measurement of cell object features |
| 05/01/1996 | EP0709468A1 A process for making the product of a nucleic acid amplification reaction incapable of being a target for further amplification, a diagnostic assay employing said process, a kit and a container suitable for carrying out said process or assay |
| 05/01/1996 | EP0709467A2 Compositions and methods for the detection of chlamydia trachomatis |
| 05/01/1996 | EP0709466A2 Compositions and methods for the simultaneous detection and quantification of multiple specific nucleic acid sequences |
| 05/01/1996 | EP0709458A1 Method for stabilizing an aqueous alkaline phosphatase solution |
| 05/01/1996 | EP0709457A1 Fructosyl amino acid oxidase and process for producing the same |
| 05/01/1996 | EP0709456A2 Microbial cholesterol-dehydrogenase, process for the preparation and use |
| 05/01/1996 | EP0708922A1 Identification of ligands by selective amplification of cells transfected with receptors |
| 05/01/1996 | EP0708841A1 Method of identifying human and animal cells capable of unlimited proliferation or tumour formation |
| 05/01/1996 | EP0708840A1 Improved methods for detecting nucleic acid sequences |
| 05/01/1996 | EP0708839A1 Improved nucleic acid reactions |
| 05/01/1996 | EP0708838A1 Use of heparanase to identify and isolate anti-heparanase compound |
| 05/01/1996 | EP0708832A1 Helicobacter pylori haemagglutinin/protease protein, nucleic acid encoding therefor and antibodies specific thereto |
| 05/01/1996 | EP0708827A1 Purification method and apparatus |
| 05/01/1996 | EP0708826A1 Production and application of transgenic mushroom mycelium and fruitbodies |
| 05/01/1996 | EP0708782A1 Sex-specific dna probe for parrots, methods and kits |
| 05/01/1996 | EP0708767A1 Haptens, tracers, immunogens and antibodies for carbazole and dibenzofuran derivatives |
| 05/01/1996 | EP0708653A1 Assay and reagents for identifying anti-proliferative agents |
| 05/01/1996 | EP0708592A1 Mts gene, mutations therein, and methods for diagnosing cancer using mts gene sequence |
| 05/01/1996 | CN1031722C Reagent for delermining alpha-amylase activity containing same as effective ingredient and method for determining it |
| 04/30/1996 | US5512661 Provides for nucleic acids encoding chimeric neurotrophic factors; for targeting active compounds to cells responsive to neurotropic factor |
| 04/30/1996 | US5512660 Purified ICAM-2 and fragment thereof |
| 04/30/1996 | US5512473 Max-interacting proteins and related molecules and methods |
| 04/30/1996 | US5512467 Acyl-peptide hydrolase and methods of production and use |
| 04/30/1996 | US5512463 Enzymatic inverse polymerase chain reaction library mutagenesis |
| 04/30/1996 | US5512462 For amplification of nucleic acid sequences longer than ten kilobases |
| 04/30/1996 | US5512458 Method of using mobile priming sites for DNA sequencing |
| 04/30/1996 | US5512452 Detecting gene expression in microorganism during infection of host |
| 04/30/1996 | US5512451 Mixture of a aromatic diacyl cyclic hydrazide, peroxidase catalyst and oxidizer |
| 04/30/1996 | US5512450 Test device for determining the presence of leukocyte cells, esterase or protease in a test sample |
| 04/30/1996 | US5512449 Method for the functional determination of protein C inhibitor |
| 04/30/1996 | US5512448 Polyethylene oxide or polyvinyl alcohol |
| 04/30/1996 | US5512446 Storage stability |
| 04/30/1996 | US5512445 Amplification of oligonucleotides |
| 04/30/1996 | US5512444 Method for determining bladder tumors by assaying for MAGE-1,2,3 or 4 |
| 04/30/1996 | US5512441 Quantative method for early detection of mutant alleles and diagnostic kits for carrying out the method |
| 04/30/1996 | US5512440 Heating with forced hot air in the absence of lysogenic agents |
| 04/30/1996 | US5512439 Oligonucleotide-linked magnetic particles and uses thereof |
| 04/30/1996 | US5512438 Inhibiting RNA expression by forming a pseudo-half-knot RNA at the target's |
| 04/30/1996 | US5512437 Method for determining head and neck squamous cell carcinomas, prostate carcinomas, and bladder tumors by assaying for mage-3 |